Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Research Report 2026(Status and Outlook)
After vaccination, the body can produce a humoral immune response. It is used to prevent infectious diseases caused by group A and group C meningococci, such as cerebrospinal meningitis and pneumonia.Meningococcal disease, caused by Neisseria meningitidis, can cause serious illness and even death. The global burden of meningococcal disease, especially serogroups A and C, drives the need for effective vaccines to prevent these infections.
The global Group A and Group C Meningococcal Polysaccharide Vaccine market size was estimated at USD 318.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Group A and Group C Meningococcal Polysaccharide Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Group A and Group C Meningococcal Polysaccharide Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Group A and Group C Meningococcal Polysaccharide Vaccine market.
Global Group A and Group C Meningococcal Polysaccharide Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Walvax
Lanzhou Institute of Biological Products
AIM Bio
Sanofi Pasteur
GSK
Hualan Bio
ZFSW
Changsheng
Kanghua Bio
Market Segmentation (by Type)
Class 1 Vaccine
Class II Vaccine
Market Segmentation (by Application)
Hospital
Clinic
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Group A and Group C Meningococcal Polysaccharide Vaccine Market
Overview of the regional outlook of the Group A and Group C Meningococcal Polysaccharide Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Group A and Group C Meningococcal Polysaccharide Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Group A and Group C Meningococcal Polysaccharide Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Group A and Group C Meningococcal Polysaccharide Vaccine market size was estimated at USD 318.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Group A and Group C Meningococcal Polysaccharide Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Group A and Group C Meningococcal Polysaccharide Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Group A and Group C Meningococcal Polysaccharide Vaccine market.
Global Group A and Group C Meningococcal Polysaccharide Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Walvax
Lanzhou Institute of Biological Products
AIM Bio
Sanofi Pasteur
GSK
Hualan Bio
ZFSW
Changsheng
Kanghua Bio
Market Segmentation (by Type)
Class 1 Vaccine
Class II Vaccine
Market Segmentation (by Application)
Hospital
Clinic
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Group A and Group C Meningococcal Polysaccharide Vaccine Market
Overview of the regional outlook of the Group A and Group C Meningococcal Polysaccharide Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Group A and Group C Meningococcal Polysaccharide Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Group A and Group C Meningococcal Polysaccharide Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Group A and Group C Meningococcal Polysaccharide Vaccine
1.2 Key Market Segments
1.2.1 Group A and Group C Meningococcal Polysaccharide Vaccine Segment by Type
1.2.2 Group A and Group C Meningococcal Polysaccharide Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GROUP A AND GROUP C MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GROUP A AND GROUP C MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Product Life Cycle
3.3 Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Group A and Group C Meningococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Group A and Group C Meningococcal Polysaccharide Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Group A and Group C Meningococcal Polysaccharide Vaccine Market Competitive Situation and Trends
3.8.1 Group A and Group C Meningococcal Polysaccharide Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Group A and Group C Meningococcal Polysaccharide Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 GROUP A AND GROUP C MENINGOCOCCAL POLYSACCHARIDE VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Group A and Group C Meningococcal Polysaccharide Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GROUP A AND GROUP C MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Group A and Group C Meningococcal Polysaccharide Vaccine Market
5.7 ESG Ratings of Leading Companies
6 GROUP A AND GROUP C MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Type (2020-2025)
6.4 Global Group A and Group C Meningococcal Polysaccharide Vaccine Price by Type (2020-2025)
7 GROUP A AND GROUP C MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Sales by Application (2020-2025)
7.3 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Growth Rate by Application (2020-2025)
8 GROUP A AND GROUP C MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET SALES BY REGION
8.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Region
8.1.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Region
8.1.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Region
8.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Region
8.2.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Region
8.2.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Region
8.3 North America
8.3.1 North America Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Country
8.3.2 North America Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Country
8.4.2 Europe Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Region
8.5.2 Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Country
8.6.2 South America Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Region
8.7.2 Middle East and Africa Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 GROUP A AND GROUP C MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Group A and Group C Meningococcal Polysaccharide Vaccine by Region(2020-2025)
9.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Group A and Group C Meningococcal Polysaccharide Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Group A and Group C Meningococcal Polysaccharide Vaccine Production
9.4.1 North America Group A and Group C Meningococcal Polysaccharide Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Group A and Group C Meningococcal Polysaccharide Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Group A and Group C Meningococcal Polysaccharide Vaccine Production
9.5.1 Europe Group A and Group C Meningococcal Polysaccharide Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Group A and Group C Meningococcal Polysaccharide Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Group A and Group C Meningococcal Polysaccharide Vaccine Production (2020-2025)
9.6.1 Japan Group A and Group C Meningococcal Polysaccharide Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Group A and Group C Meningococcal Polysaccharide Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Group A and Group C Meningococcal Polysaccharide Vaccine Production (2020-2025)
9.7.1 China Group A and Group C Meningococcal Polysaccharide Vaccine Production Growth Rate (2020-2025)
9.7.2 China Group A and Group C Meningococcal Polysaccharide Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Walvax
10.1.1 Walvax Basic Information
10.1.2 Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
10.1.3 Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Product Market Performance
10.1.4 Walvax Business Overview
10.1.5 Walvax SWOT Analysis
10.1.6 Walvax Recent Developments
10.2 Lanzhou Institute of Biological Products
10.2.1 Lanzhou Institute of Biological Products Basic Information
10.2.2 Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
10.2.3 Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Product Market Performance
10.2.4 Lanzhou Institute of Biological Products Business Overview
10.2.5 Lanzhou Institute of Biological Products SWOT Analysis
10.2.6 Lanzhou Institute of Biological Products Recent Developments
10.3 AIM Bio
10.3.1 AIM Bio Basic Information
10.3.2 AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
10.3.3 AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product Market Performance
10.3.4 AIM Bio Business Overview
10.3.5 AIM Bio SWOT Analysis
10.3.6 AIM Bio Recent Developments
10.4 Sanofi Pasteur
10.4.1 Sanofi Pasteur Basic Information
10.4.2 Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
10.4.3 Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Product Market Performance
10.4.4 Sanofi Pasteur Business Overview
10.4.5 Sanofi Pasteur Recent Developments
10.5 GSK
10.5.1 GSK Basic Information
10.5.2 GSK Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
10.5.3 GSK Group A and Group C Meningococcal Polysaccharide Vaccine Product Market Performance
10.5.4 GSK Business Overview
10.5.5 GSK Recent Developments
10.6 Hualan Bio
10.6.1 Hualan Bio Basic Information
10.6.2 Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
10.6.3 Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product Market Performance
10.6.4 Hualan Bio Business Overview
10.6.5 Hualan Bio Recent Developments
10.7 ZFSW
10.7.1 ZFSW Basic Information
10.7.2 ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
10.7.3 ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Product Market Performance
10.7.4 ZFSW Business Overview
10.7.5 ZFSW Recent Developments
10.8 Changsheng
10.8.1 Changsheng Basic Information
10.8.2 Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
10.8.3 Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Product Market Performance
10.8.4 Changsheng Business Overview
10.8.5 Changsheng Recent Developments
10.9 Kanghua Bio
10.9.1 Kanghua Bio Basic Information
10.9.2 Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
10.9.3 Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product Market Performance
10.9.4 Kanghua Bio Business Overview
10.9.5 Kanghua Bio Recent Developments
11 GROUP A AND GROUP C MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET FORECAST BY REGION
11.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast
11.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Region
11.2.4 South America Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Group A and Group C Meningococcal Polysaccharide Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Group A and Group C Meningococcal Polysaccharide Vaccine by Type (2026-2035)
12.1.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Group A and Group C Meningococcal Polysaccharide Vaccine by Type (2026-2035)
12.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Forecast by Application (2026-2035)
12.2.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Group A and Group C Meningococcal Polysaccharide Vaccine
1.2 Key Market Segments
1.2.1 Group A and Group C Meningococcal Polysaccharide Vaccine Segment by Type
1.2.2 Group A and Group C Meningococcal Polysaccharide Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GROUP A AND GROUP C MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GROUP A AND GROUP C MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Product Life Cycle
3.3 Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Group A and Group C Meningococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Group A and Group C Meningococcal Polysaccharide Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Group A and Group C Meningococcal Polysaccharide Vaccine Market Competitive Situation and Trends
3.8.1 Group A and Group C Meningococcal Polysaccharide Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Group A and Group C Meningococcal Polysaccharide Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 GROUP A AND GROUP C MENINGOCOCCAL POLYSACCHARIDE VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Group A and Group C Meningococcal Polysaccharide Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GROUP A AND GROUP C MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Group A and Group C Meningococcal Polysaccharide Vaccine Market
5.7 ESG Ratings of Leading Companies
6 GROUP A AND GROUP C MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Type (2020-2025)
6.4 Global Group A and Group C Meningococcal Polysaccharide Vaccine Price by Type (2020-2025)
7 GROUP A AND GROUP C MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Sales by Application (2020-2025)
7.3 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Growth Rate by Application (2020-2025)
8 GROUP A AND GROUP C MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET SALES BY REGION
8.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Region
8.1.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Region
8.1.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Region
8.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Region
8.2.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Region
8.2.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Region
8.3 North America
8.3.1 North America Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Country
8.3.2 North America Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Country
8.4.2 Europe Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Region
8.5.2 Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Country
8.6.2 South America Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Region
8.7.2 Middle East and Africa Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 GROUP A AND GROUP C MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Group A and Group C Meningococcal Polysaccharide Vaccine by Region(2020-2025)
9.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Group A and Group C Meningococcal Polysaccharide Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Group A and Group C Meningococcal Polysaccharide Vaccine Production
9.4.1 North America Group A and Group C Meningococcal Polysaccharide Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Group A and Group C Meningococcal Polysaccharide Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Group A and Group C Meningococcal Polysaccharide Vaccine Production
9.5.1 Europe Group A and Group C Meningococcal Polysaccharide Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Group A and Group C Meningococcal Polysaccharide Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Group A and Group C Meningococcal Polysaccharide Vaccine Production (2020-2025)
9.6.1 Japan Group A and Group C Meningococcal Polysaccharide Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Group A and Group C Meningococcal Polysaccharide Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Group A and Group C Meningococcal Polysaccharide Vaccine Production (2020-2025)
9.7.1 China Group A and Group C Meningococcal Polysaccharide Vaccine Production Growth Rate (2020-2025)
9.7.2 China Group A and Group C Meningococcal Polysaccharide Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Walvax
10.1.1 Walvax Basic Information
10.1.2 Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
10.1.3 Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Product Market Performance
10.1.4 Walvax Business Overview
10.1.5 Walvax SWOT Analysis
10.1.6 Walvax Recent Developments
10.2 Lanzhou Institute of Biological Products
10.2.1 Lanzhou Institute of Biological Products Basic Information
10.2.2 Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
10.2.3 Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Product Market Performance
10.2.4 Lanzhou Institute of Biological Products Business Overview
10.2.5 Lanzhou Institute of Biological Products SWOT Analysis
10.2.6 Lanzhou Institute of Biological Products Recent Developments
10.3 AIM Bio
10.3.1 AIM Bio Basic Information
10.3.2 AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
10.3.3 AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product Market Performance
10.3.4 AIM Bio Business Overview
10.3.5 AIM Bio SWOT Analysis
10.3.6 AIM Bio Recent Developments
10.4 Sanofi Pasteur
10.4.1 Sanofi Pasteur Basic Information
10.4.2 Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
10.4.3 Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Product Market Performance
10.4.4 Sanofi Pasteur Business Overview
10.4.5 Sanofi Pasteur Recent Developments
10.5 GSK
10.5.1 GSK Basic Information
10.5.2 GSK Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
10.5.3 GSK Group A and Group C Meningococcal Polysaccharide Vaccine Product Market Performance
10.5.4 GSK Business Overview
10.5.5 GSK Recent Developments
10.6 Hualan Bio
10.6.1 Hualan Bio Basic Information
10.6.2 Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
10.6.3 Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product Market Performance
10.6.4 Hualan Bio Business Overview
10.6.5 Hualan Bio Recent Developments
10.7 ZFSW
10.7.1 ZFSW Basic Information
10.7.2 ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
10.7.3 ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Product Market Performance
10.7.4 ZFSW Business Overview
10.7.5 ZFSW Recent Developments
10.8 Changsheng
10.8.1 Changsheng Basic Information
10.8.2 Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
10.8.3 Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Product Market Performance
10.8.4 Changsheng Business Overview
10.8.5 Changsheng Recent Developments
10.9 Kanghua Bio
10.9.1 Kanghua Bio Basic Information
10.9.2 Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
10.9.3 Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product Market Performance
10.9.4 Kanghua Bio Business Overview
10.9.5 Kanghua Bio Recent Developments
11 GROUP A AND GROUP C MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET FORECAST BY REGION
11.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast
11.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Region
11.2.4 South America Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Group A and Group C Meningococcal Polysaccharide Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Group A and Group C Meningococcal Polysaccharide Vaccine by Type (2026-2035)
12.1.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Group A and Group C Meningococcal Polysaccharide Vaccine by Type (2026-2035)
12.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Forecast by Application (2026-2035)
12.2.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Type (M USD)
Table 4. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Application
Table 5. Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Group A and Group C Meningococcal Polysaccharide Vaccine as of 2025)
Table 11. Global Market Group A and Group C Meningococcal Polysaccharide Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Group A and Group C Meningococcal Polysaccharide Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Type (K MT)
Table 27. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Type (M USD)
Table 28. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales (K MT) by Type (2020-2025)
Table 29. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2020-2025)
Table 30. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size (M USD) by Type (2020-2025)
Table 31. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Share by Type (2020-2025)
Table 32. Global Group A and Group C Meningococcal Polysaccharide Vaccine Price (USD/KG) by Type (2020-2025)
Table 33. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales (K MT) by Application
Table 34. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Application
Table 35. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Application (2020-2025) & (K MT)
Table 36. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2020-2025)
Table 37. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Share by Application (2020-2025)
Table 39. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Growth Rate by Application (2020-2025)
Table 40. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Region (2020-2025) & (K MT)
Table 41. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Region (2020-2025)
Table 42. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Region (2020-2025)
Table 44. North America Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Country (2020-2025) & (K MT)
Table 45. North America Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Country (2020-2025) & (K MT)
Table 51. South America Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Group A and Group C Meningococcal Polysaccharide Vaccine Production (K MT) by Region(2020-2025)
Table 55. Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share by Region (2020-2025)
Table 57. Global Group A and Group C Meningococcal Polysaccharide Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Group A and Group C Meningococcal Polysaccharide Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Group A and Group C Meningococcal Polysaccharide Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Group A and Group C Meningococcal Polysaccharide Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Walvax Basic Information
Table 63. Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
Table 64. Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Walvax Business Overview
Table 66. Walvax SWOT Analysis
Table 67. Walvax Recent Developments
Table 68. Lanzhou Institute of Biological Products Basic Information
Table 69. Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
Table 70. Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Lanzhou Institute of Biological Products Business Overview
Table 72. Lanzhou Institute of Biological Products SWOT Analysis
Table 73. Lanzhou Institute of Biological Products Recent Developments
Table 74. AIM Bio Basic Information
Table 75. AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
Table 76. AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. AIM Bio Business Overview
Table 78. AIM Bio SWOT Analysis
Table 79. AIM Bio Recent Developments
Table 80. Sanofi Pasteur Basic Information
Table 81. Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
Table 82. Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Sanofi Pasteur Business Overview
Table 84. Sanofi Pasteur Recent Developments
Table 85. GSK Basic Information
Table 86. GSK Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
Table 87. GSK Group A and Group C Meningococcal Polysaccharide Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. GSK Business Overview
Table 89. GSK Recent Developments
Table 90. Hualan Bio Basic Information
Table 91. Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
Table 92. Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Hualan Bio Business Overview
Table 94. Hualan Bio Recent Developments
Table 95. ZFSW Basic Information
Table 96. ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
Table 97. ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. ZFSW Business Overview
Table 99. ZFSW Recent Developments
Table 100. Changsheng Basic Information
Table 101. Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
Table 102. Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Changsheng Business Overview
Table 104. Changsheng Recent Developments
Table 105. Kanghua Bio Basic Information
Table 106. Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
Table 107. Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Kanghua Bio Business Overview
Table 109. Kanghua Bio Recent Developments
Table 110. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 111. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 112. North America Group A and Group C Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 113. North America Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 114. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 115. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 116. Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 117. Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 118. South America Group A and Group C Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 119. South America Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 120. Middle East and Africa Group A and Group C Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2026-2035) & (Units)
Table 121. Middle East and Africa Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 122. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Forecast by Type (2026-2035) & (K MT)
Table 123. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Type (2026-2035) & (M USD)
Table 124. Global Group A and Group C Meningococcal Polysaccharide Vaccine Price Forecast by Type (2026-2035) & (USD/KG)
Table 125. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales (K MT) Forecast by Application (2026-2035)
Table 126. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Type (M USD)
Table 4. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Application
Table 5. Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Group A and Group C Meningococcal Polysaccharide Vaccine as of 2025)
Table 11. Global Market Group A and Group C Meningococcal Polysaccharide Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Group A and Group C Meningococcal Polysaccharide Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Type (K MT)
Table 27. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Type (M USD)
Table 28. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales (K MT) by Type (2020-2025)
Table 29. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2020-2025)
Table 30. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size (M USD) by Type (2020-2025)
Table 31. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Share by Type (2020-2025)
Table 32. Global Group A and Group C Meningococcal Polysaccharide Vaccine Price (USD/KG) by Type (2020-2025)
Table 33. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales (K MT) by Application
Table 34. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Application
Table 35. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Application (2020-2025) & (K MT)
Table 36. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2020-2025)
Table 37. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Share by Application (2020-2025)
Table 39. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Growth Rate by Application (2020-2025)
Table 40. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Region (2020-2025) & (K MT)
Table 41. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Region (2020-2025)
Table 42. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Region (2020-2025)
Table 44. North America Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Country (2020-2025) & (K MT)
Table 45. North America Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Country (2020-2025) & (K MT)
Table 51. South America Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Group A and Group C Meningococcal Polysaccharide Vaccine Production (K MT) by Region(2020-2025)
Table 55. Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share by Region (2020-2025)
Table 57. Global Group A and Group C Meningococcal Polysaccharide Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Group A and Group C Meningococcal Polysaccharide Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Group A and Group C Meningococcal Polysaccharide Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Group A and Group C Meningococcal Polysaccharide Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Walvax Basic Information
Table 63. Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
Table 64. Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Walvax Business Overview
Table 66. Walvax SWOT Analysis
Table 67. Walvax Recent Developments
Table 68. Lanzhou Institute of Biological Products Basic Information
Table 69. Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
Table 70. Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Lanzhou Institute of Biological Products Business Overview
Table 72. Lanzhou Institute of Biological Products SWOT Analysis
Table 73. Lanzhou Institute of Biological Products Recent Developments
Table 74. AIM Bio Basic Information
Table 75. AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
Table 76. AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. AIM Bio Business Overview
Table 78. AIM Bio SWOT Analysis
Table 79. AIM Bio Recent Developments
Table 80. Sanofi Pasteur Basic Information
Table 81. Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
Table 82. Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Sanofi Pasteur Business Overview
Table 84. Sanofi Pasteur Recent Developments
Table 85. GSK Basic Information
Table 86. GSK Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
Table 87. GSK Group A and Group C Meningococcal Polysaccharide Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. GSK Business Overview
Table 89. GSK Recent Developments
Table 90. Hualan Bio Basic Information
Table 91. Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
Table 92. Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Hualan Bio Business Overview
Table 94. Hualan Bio Recent Developments
Table 95. ZFSW Basic Information
Table 96. ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
Table 97. ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. ZFSW Business Overview
Table 99. ZFSW Recent Developments
Table 100. Changsheng Basic Information
Table 101. Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
Table 102. Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Changsheng Business Overview
Table 104. Changsheng Recent Developments
Table 105. Kanghua Bio Basic Information
Table 106. Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product Overview
Table 107. Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Kanghua Bio Business Overview
Table 109. Kanghua Bio Recent Developments
Table 110. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 111. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 112. North America Group A and Group C Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 113. North America Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 114. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 115. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 116. Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 117. Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 118. South America Group A and Group C Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 119. South America Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 120. Middle East and Africa Group A and Group C Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2026-2035) & (Units)
Table 121. Middle East and Africa Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 122. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Forecast by Type (2026-2035) & (K MT)
Table 123. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Type (2026-2035) & (M USD)
Table 124. Global Group A and Group C Meningococcal Polysaccharide Vaccine Price Forecast by Type (2026-2035) & (USD/KG)
Table 125. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales (K MT) Forecast by Application (2026-2035)
Table 126. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Group A and Group C Meningococcal Polysaccharide Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size (M USD), 2025-2035
Figure 5. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size (M USD) (2020-2035)
Figure 6. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Group A and Group C Meningococcal Polysaccharide Vaccine Product Life Cycle
Figure 13. Group A and Group C Meningococcal Polysaccharide Vaccine Sales Share by Manufacturers in 2025
Figure 14. Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Share by Manufacturers in 2025
Figure 15. Group A and Group C Meningococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Group A and Group C Meningococcal Polysaccharide Vaccine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Group A and Group C Meningococcal Polysaccharide Vaccine Revenue in 2025
Figure 18. Industry Chain Map of Group A and Group C Meningococcal Polysaccharide Vaccine
Figure 19. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market PEST Analysis
Figure 20. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Share by Type
Figure 27. Sales Market Share of Group A and Group C Meningococcal Polysaccharide Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Group A and Group C Meningococcal Polysaccharide Vaccine by Type in 2025
Figure 29. Market Share of Group A and Group C Meningococcal Polysaccharide Vaccine by Type (2020-2025)
Figure 30. Market Share of Group A and Group C Meningococcal Polysaccharide Vaccine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Share by Application
Figure 33. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Application in 2025
Figure 35. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Share by Application (2020-2025)
Figure 36. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Share by Application in 2025
Figure 37. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Region (2020-2025)
Figure 40. North America Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Country in 2024
Figure 43. North America Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Country in 2024
Figure 45. U.S. Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Group A and Group C Meningococcal Polysaccharide Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Group A and Group C Meningococcal Polysaccharide Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Group A and Group C Meningococcal Polysaccharide Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Group A and Group C Meningococcal Polysaccharide Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Country in 2024
Figure 55. Germany Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Region in 2024
Figure 68. China Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Country in 2024
Figure 80. South America Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Country in 2024
Figure 82. Brazil Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Region in 2024
Figure 92. Saudi Arabia Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Group A and Group C Meningococcal Polysaccharide Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Group A and Group C Meningococcal Polysaccharide Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Group A and Group C Meningococcal Polysaccharide Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Group A and Group C Meningococcal Polysaccharide Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Share Forecast by Type (2026-2035)
Figure 111. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Forecast by Application (2026-2035)
Figure 112. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Group A and Group C Meningococcal Polysaccharide Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size (M USD), 2025-2035
Figure 5. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size (M USD) (2020-2035)
Figure 6. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Group A and Group C Meningococcal Polysaccharide Vaccine Product Life Cycle
Figure 13. Group A and Group C Meningococcal Polysaccharide Vaccine Sales Share by Manufacturers in 2025
Figure 14. Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Share by Manufacturers in 2025
Figure 15. Group A and Group C Meningococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Group A and Group C Meningococcal Polysaccharide Vaccine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Group A and Group C Meningococcal Polysaccharide Vaccine Revenue in 2025
Figure 18. Industry Chain Map of Group A and Group C Meningococcal Polysaccharide Vaccine
Figure 19. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market PEST Analysis
Figure 20. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Share by Type
Figure 27. Sales Market Share of Group A and Group C Meningococcal Polysaccharide Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Group A and Group C Meningococcal Polysaccharide Vaccine by Type in 2025
Figure 29. Market Share of Group A and Group C Meningococcal Polysaccharide Vaccine by Type (2020-2025)
Figure 30. Market Share of Group A and Group C Meningococcal Polysaccharide Vaccine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Share by Application
Figure 33. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Application in 2025
Figure 35. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Share by Application (2020-2025)
Figure 36. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Share by Application in 2025
Figure 37. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Region (2020-2025)
Figure 40. North America Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Country in 2024
Figure 43. North America Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Country in 2024
Figure 45. U.S. Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Group A and Group C Meningococcal Polysaccharide Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Group A and Group C Meningococcal Polysaccharide Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Group A and Group C Meningococcal Polysaccharide Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Group A and Group C Meningococcal Polysaccharide Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Country in 2024
Figure 55. Germany Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Region in 2024
Figure 68. China Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Country in 2024
Figure 80. South America Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Country in 2024
Figure 82. Brazil Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Region in 2024
Figure 92. Saudi Arabia Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Group A and Group C Meningococcal Polysaccharide Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Group A and Group C Meningococcal Polysaccharide Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Group A and Group C Meningococcal Polysaccharide Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Group A and Group C Meningococcal Polysaccharide Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Share Forecast by Type (2026-2035)
Figure 111. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Forecast by Application (2026-2035)
Figure 112. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Share Forecast by Application (2026-2035)
